Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Platelet Activation in Patients with Unstable Angina

  • Conference paper
Unstable Angina

Abstract

Unstable angina has become accepted as a clinical entity of coronary heart disease associated with a high risk of myocardial infarction and sudden cardiac death [1–4]. In recent years the pathogenetic mechanisms of unstable angina have been intensively investigated with the aim of better characterizing this high-risk group of patients. Evidence is now accumulating that platelet activation plays a major role in a complex cascade of events originating in arteriosclerotic plaque rupture and resulting in occlusive thrombus formation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braunwald E (1989) Unstable angina, a classification. Circulation 80: 410–414

    Article  PubMed  CAS  Google Scholar 

  2. Fowler NO (1971) “Preinfarctional” angina. Circulation 44, 5:755–758

    Google Scholar 

  3. Julian DG (1985) The natural history of unstable angina. In: Unstable angina. Current concepts and management. Schattauer, Stuttgart, pp 65–70

    Google Scholar 

  4. Wood P (1961) Acute and subacute coronary insufficiency. Br Med J 1779–1782

    Google Scholar 

  5. Born GVR (1985) Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. Circulation 72, 4: 741–746

    Article  PubMed  CAS  Google Scholar 

  6. Kaplan K, Broekman MJ, Chernoff A, Leszni GR, Drillings M (1979) Platelet a-granule proteins: studies on release and subcellular localization. Blood 53, 4: 604–618

    PubMed  CAS  Google Scholar 

  7. Kohler N, Lipton A (1974) Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87: 297–301

    Article  PubMed  CAS  Google Scholar 

  8. Mills DC, Robb JA, Roberts GCK (1968) The release of nucleotides, 5-hydroxytryptomine and enzymes from human blood platelets during aggregation. J Physiol 195: 715–729

    PubMed  CAS  Google Scholar 

  9. Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B (1976) Identification of an enzyme in platelet microsomes which generates thromboxane AZ from prostaglandin endoperoxides. Nature 261: 558

    Article  PubMed  CAS  Google Scholar 

  10. Libby P, Warner St, Salomon R, Birinyi L (1988) Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 318, 23: 1493–1498

    Article  PubMed  CAS  Google Scholar 

  11. Ross R, Glomset J, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71, 4: 1207–1210

    Article  PubMed  CAS  Google Scholar 

  12. Cazenave JP, Benveniste J, Mustard JF (1979) Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs. Lab Invest 41, 3: 275–285

    PubMed  CAS  Google Scholar 

  13. Kaplan KL, Owen J (1981) Plasma levels of ß-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 57, 2: 199–202

    PubMed  CAS  Google Scholar 

  14. Moncada S, Gryglewski R, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endo-peroxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663

    Article  PubMed  CAS  Google Scholar 

  15. Kinlough-Rathbone RL, Mustard JF, Perry DW, Dejana E, Cazenave JP, Packham MA, Harfenist EJ (1983) Factors influencing the deaggregation of human and rabbit platelets. Thromb Haemostas 49, 3: 162–167

    CAS  Google Scholar 

  16. Shattil SJ, Bennett JS (1980) Platelet and their membranes in hemostasis: physiology and pathophysiology. Ann Int Med 94: 108–118

    Google Scholar 

  17. Adams PH, Fuster V, Badimon L, Badimon JJ, Chesebro J (1987) Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. Am J Cardiol 60:9G–16G

    Article  PubMed  CAS  Google Scholar 

  18. Kramer C, Gerhardt HJ, Bleifeld W (1974) A model for closure of arterial vessels with special regard to the coronary arteries. Bas Res Cardiol 69: 585–596

    Article  CAS  Google Scholar 

  19. Wurzinger L, Blasberg P, Schmid-Schönbein H (1984) Rheologische Betrachtung der Abscheidungsthrombose. VASA 13: 305–310

    PubMed  CAS  Google Scholar 

  20. Folts JD, Crowell EB, Rowe GG (1976) Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 54: 365–370

    PubMed  CAS  Google Scholar 

  21. Falk E (1985) Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 71: 699–708

    Article  PubMed  CAS  Google Scholar 

  22. Davies MJ, Thomas AC (1985) Plaque fissuring — the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 534: 363–373

    Article  Google Scholar 

  23. The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312: 932–936

    Google Scholar 

  24. Alison HW, Russell RO, Mantle JA, Kouchoukos N, Moraski RE, Rackley GH (1978) Coronary anatomy and arteriography in patients with unstable angina pectoris. Am J Cardiol 41: 204–209

    Article  PubMed  CAS  Google Scholar 

  25. Neill WA, Ritzmann LW, Selden R (1977) The pathophysiologic basis of acute coronary insufficiency. Observations favoring the hypothesis of intermittent reversible coronary obstruction. Am Heart J 94: 439–444

    Article  PubMed  CAS  Google Scholar 

  26. Ambrose JA, Hjemdahl-Monsen CE, Borrico S, Gorlin R, Fuster V (1988) Angiographie demonstration of a common link between unstable angina pectoris and non-Q-wave acute myocardial infarction. Am J Cardiol 61: 244–247

    Article  PubMed  CAS  Google Scholar 

  27. Nellessen U, Hecker H, Danciu V, Specht S, Lichtlen PR, Borst HG (1986) Instabile Angina pectoris: Krankheitsbild and Verlauf neu überprüft. Z Kardiol 75: 707–718

    PubMed  CAS  Google Scholar 

  28. Fuster V, Badimon L, Cohen M, Ambrose J, Badimon JJ, Chesebro J (1988) Insights into the pathogenesis of acute ischemic syndromes. Circulation 77: 1213–1220

    Article  PubMed  CAS  Google Scholar 

  29. Vermylen J, Verstraete M, Fuster V (1986) Role of platelet activation and fibrin formation in thrombogenesis. J Am Coll Cardiol 8:2B–9B

    Article  PubMed  CAS  Google Scholar 

  30. Terres W, Hamm CW, Kupper W, Bleifeld W (1988) Thrombozytenfunktion bei instabiler Angina pectoris. Dtsch Med Wschr 113: 1182–1186

    Article  PubMed  CAS  Google Scholar 

  31. Chesebro JH, Fuster V (1987) The therapeutic challenge of plaque rupture: value of biochemical markers. J Am Coll Cardiol 10: 1005–1006

    Article  Google Scholar 

  32. Hamm CW, Bleifeld W (1988) Unstable angina; current concepts of medical management. Cardiovasc Drugs Therapy 2: 333–339

    Article  CAS  Google Scholar 

  33. Granström E, Diczfalusy U, Hamberg M, Hansson G, Malrosten C, Samuelsson B (1982) Thromboxane AZ: biosynthesis and effects on platelets. Prostaglandins and the Cardiovascular System 15–59

    Google Scholar 

  34. Patrono C, Ciabattoni G, Pugliese F, Perucci A, Blair IA, FitzGerald GA (1986) Estimated rate of thromboxane secretion into the circulation of normal humans. J Clin Invest 77: 1–6

    Article  Google Scholar 

  35. Roberts JL, Brash AR, Oates JA (1982) Metabolic fate of thromboxane A, and prostacyclin. Prostaglandins and the Cardiovascular System 213–223

    Google Scholar 

  36. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ (1988) Clinical implications of prostaglandin and thromboxane A, formation. New Engl J Med 319: 689–698

    Article  PubMed  CAS  Google Scholar 

  37. Roberts JL, Sweetman BJ, Oates JA (1981) Metabolism of thromboxane B, in man. Identification of twenty urinary metabolites. J Biol Chem 256: 8384–8393

    PubMed  CAS  Google Scholar 

  38. Nichols AB, Owen J, Grossman BA, Marcella JJ, Fleisher LN, Lee MML (1984) Effect of heparin bonding on catheter induced fibrin formation and platelet activation. Circulation 70: 843–850

    Article  PubMed  CAS  Google Scholar 

  39. Sobel M, Salzman EW, Davies GC, Handin RI, Sweeney RN, Ploetz J, Kurland G (1981) Circulating platelet products in unstable angina pectoris. Circulation 63: 300–306

    Article  PubMed  CAS  Google Scholar 

  40. De Boer AC, Turpie AG, Butt RW, Johnston RV, Genton E (1982) Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation 66: 327–333

    Article  PubMed  Google Scholar 

  41. Hirsch PD, Hillis D, Campbell WB, Firth BG, Willerson JT (1981) Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med 304: 685–691

    Article  Google Scholar 

  42. Mehta J, Mehta P, Feldman R, Horalek C (1984) Thromboxane release in coronary artery disease: spontaneous versus pacing-induced angina. Am Heart J 107: 286–292

    Article  PubMed  CAS  Google Scholar 

  43. Neri Semen GG, Gensini GF, Abbate R, Prisco D, Rogasi PG, Laureano R, Casolo GC, Fantini F, Donato MD, Dabizzi RP (1985) Abnormal cardiocoronary thromboxane A, production in patients with unstable angina. Am Heart J 109: 732–738

    Article  Google Scholar 

  44. Lawson JA, Patrono C, Ciabattoni G, FitzGerald GA (1986) Long-lived enzymatic metabolites of thromboxane BZ in the human circulation. Analyt Biochem 155: 198–205

    Article  PubMed  CAS  Google Scholar 

  45. Westlund P, Kumlin M, Nordenström A, Granström E (1986) Circulating and urinary thromboxane BZ metabolites in the rabbit: 11-dehydro-thromboxane B, as parameter of thromboxane production. Prostaglandins 31: 413–444

    Article  PubMed  CAS  Google Scholar 

  46. Patrono C, Ciabattoni G, Patrignani P, Filabozzi P, Pinca E, Satta MA, Van Dorne D, Cinotti GA, Pugliese F, Pierucci A, Simonetti BM (1983) Evidence for a renal origin of urinary thromboxane B, in health and disease. Adv Prostaglandin, Thromboxane, Leukotriene Res 11: 493–498

    CAS  Google Scholar 

  47. FitzGerald GA, Pedersen AK, Patrono C (1983) Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 67: 1174–1177

    Article  PubMed  CAS  Google Scholar 

  48. Siess W, Lorenz R, Roth P, Weber PC (1982) Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion. Circulation 66: 44–48

    Article  PubMed  CAS  Google Scholar 

  49. Gallino A, Haeberli A, Baur HR, Straub PW (1985) Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. Circulation 72: 27–30

    Article  PubMed  CAS  Google Scholar 

  50. Théroux P, Latour JG, Léger-Gauthier C, De Lara J (1987) Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 5: 156–162

    Article  Google Scholar 

  51. Smitherman T, Milam M, Woo J, Willerson JT, Frenkel EP (1981) Elevated beta thromboglobulin in peripheral venous blood of patients with acute mocardial ischemia: Direct evidence for enhanced platelet reactivity in vivo. Am J Cardiot 48: 395–402

    Article  CAS  Google Scholar 

  52. Bugiardini R, Chierchia S, Crea F, Gallino A, Wild ST, Roskove A, Lenzi S, Maseri A (1984) Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation. Am Heart J 108: 255–260

    Article  PubMed  CAS  Google Scholar 

  53. Dusting GJ, Moncada S, Vane JR (1979) Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems. Prog Cardiovasc Dis 21: 405–430

    Article  PubMed  CAS  Google Scholar 

  54. Weksler B (1984) Prostaglandins and vascular function. Circulation 70 (Suppl III): 63–71

    Google Scholar 

  55. Needelmann P, Kaley G (1978) Cardiac and coronary prostaglandin synthesis and function. N Engl J Med 298: 1122–1128

    Article  Google Scholar 

  56. Roy L, Knapp HR, Robertson RM, FitzGerald GA (1985) Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. Circulation 71: 434–440

    Article  PubMed  CAS  Google Scholar 

  57. Falardeau P, Oates A, Brash AR (1981) Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. Analyt Biochem 115: 359–367

    Article  PubMed  CAS  Google Scholar 

  58. Fischer S, Scherer B, Weber PC (1983) Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F 1, and 2,3-dinor-6-ketoprostaglandin F 1 studied by gas chromatography — mass spectrometry. Biochim Biophys Acta 750: 127–133

    PubMed  CAS  Google Scholar 

  59. FitzGerald GA, Smith B, Pedersen AK, Brash A (1984) Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. New Engl J Med 310: 1065–1068

    Article  PubMed  CAS  Google Scholar 

  60. FitzGerald GA, Reilly IA, Pedersen AK (1985) The biochemical pharmacology of thromboxane synthetase inhibition in man. Circulation 72: 1194–1201

    Article  PubMed  CAS  Google Scholar 

  61. Patrono C, Ciabattoni G, Patrignani P, Pugliese F, Filabozzi P, Catella F, Davi G, Forni L (1985) Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 72: 1177–1184

    Article  PubMed  CAS  Google Scholar 

  62. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA (1986) Platelet activation in unstable coronary disease. New Engl J Med 315: 983–989

    Article  PubMed  CAS  Google Scholar 

  63. Hamm CW, Lorenz R, Bleifeld W, Kupper W, Wober W, Weber PC (1987) Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 10: 998–1004

    Article  PubMed  CAS  Google Scholar 

  64. Gazes PC, Mobley EM, Faris HM, Duncan RC, Humphries GB (1973) Preinfarction (unstable) angina — a prospective study — ten year follow-up. Circulation 48: 331–337

    PubMed  CAS  Google Scholar 

  65. Hook BG, Schumacher WA, Lee DL, Jolly StR, Lucchesi BR (1985) Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis. J Cardiovasc Pharmacol 7: 174–181

    Article  PubMed  CAS  Google Scholar 

  66. Bunting S, Monada S, Vane JR (1983) The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. British Med Bull 39: 271–276

    CAS  Google Scholar 

  67. Lorenz R, Hamm CW, Riesner H, Bleifeld W, Weber PC (1990) Urinary thromboxane excretion in patients presenting with acute severe chest pain. J Int Med

    Google Scholar 

  68. Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Hablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey JB, Tanser PH (1985) Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 313: 1369–1375

    Article  PubMed  CAS  Google Scholar 

  69. Lewis HD, Davies JW, Archibald DG, Steinke WE, Smithermann TC, Doherty JE, Schnaper HW, Le Winter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 309: 396–403

    Article  PubMed  Google Scholar 

  70. Théroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, DeGuise P, Pelletier GB, Rinzler D, Waters DD (1988) Aspirin, heparin, or both to treat acute unstable angina. New Engl J Med 319: 1105–1111

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Kardiologie, Medizinische Klinik, Universitätskrankenhaus Eppendorf, Martinistrasse 52, 2000, Hamburg 20, West Germany

    W. Bleifeld

Authors
  1. C. W. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Terres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Bleifeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätskrankenhaus Eppendorf — Kardiologie, Martinistraße 52, 2000, Hamburg 20, Germany

    Walter Bleifeld Professor Dr.  & Christian W. Hamm Privatdozent Dr.  & 

  2. Department of Medicine, Brigham and Women’ Hospital, Harvard Medical School, 75 Francis Street, 02115, Boston, MA, USA

    Eugene Braunwald Professor Dr.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hamm, C.W., Terres, W., Bleifeld, W. (1990). Platelet Activation in Patients with Unstable Angina. In: Bleifeld, W., Hamm, C.W., Braunwald, E. (eds) Unstable Angina. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61288-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61288-6_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64778-9

  • Online ISBN: 978-3-642-61288-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation